Sign in

CIK 0001840233

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851623397
Phone
+1 617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-06-11 Clancy Paul J Director Grant or award · Stock Option (right to buy) +31,000 31,000
2024-06-14 Clancy Paul J Director Grant or award · Stock Option (right to buy) +25,000 25,000
2023-06-12 Clancy Paul J Director Grant or award · Stock Option (right to buy) +13,200 13,200
2022-06-15 Clancy Paul J Director Grant or award · Stock Option (right to buy) +13,200 13,200
2021-10-26 Clancy Paul J Director Grant or award · Stock Option (right to buy) +44,033 44,033
2021-10-26 Clancy Paul J Director Grant or award · Stock Option (right to buy) +65,528 65,528

Page 1 of 1 · 6 trades